GlassScriptPhysician profile
Jerome V Benz
NPI 1104813468
$1,206.10
in general payments reported to CMS, 2019-2025
18 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $90.44 · 2021: $35.94 · 2022: $133 · 2023: $67.43 · 2024: $270 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $280.62 | 2019 | |
| Alcon Vision LLC | $245.52 | 2019-2025 | Clareon, Tryptyr, Centurion |
| Abbvie INC. | $156.11 | 2022-2024 | Durysta |
| Glaukos Corporation | $127.42 | 2022-2025 | Idosetr |
| Bausch & Lomb Americas INC. | $69.24 | 2023-2024 | Envista Mx60 Iol, Ic-8 Apthera Iol, Xiidra |
| Oyster Point Pharma, INC. | $61.17 | 2022-2023 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $47.01 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $28.72 | 2025 | Xdemvy |
| Rxsight INC | $25.86 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Shire North American Group INC | $24.08 | 2019 | |
| Allergan, INC. | $23.06 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.76 | 2019 | |
| Ivantis, INC | $18.34 | 2020 | |
| Biotissue Holdings INC. | $17.62 | 2024 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $15.79 | 2019 | |
| Eyevance Pharmaceuticals LLC | $13.66 | 2020 | |
| Sight Sciences, INC. | $12.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Benz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.